Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Haim Werner

Showing results (81-90 of 117) with videos related to

Pageof 12
Sort By:
Endocrinology|May 8, 2004
Transcriptional activation of the insulin-like growth factor I receptor gene by the Kruppel-like factor 6 (KLF6) tumor suppressor protein: potential interactions between KLF6 and p53Moran Rubinstein, Gila Idelman, Stephen R Plymate, et al.
Cancer Letters|May 30, 2006
A novel EWS-WT1 gene fusion product in desmoplastic small round cell tumor is a potent transactivator of the insulin-like growth factor-I receptor (IGF-IR) geneHaim Werner, Gila Idelman, Moran Rubinstein, et al.
European Journal of Cancer (Oxford, England : 1990)|April 1, 2011
Insulin-like growth factor-I receptor (IGF-IR) targeting with monoclonal antibody cixutumumab (IMC-A12) inhibits IGF-I action in endometrial cancer cellsZohar Attias-Geva, Itay Bentov, Dale L Ludwig, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|September 14, 2017
Reduced Serum IGF-1 Associated With Hepatic Osteodystrophy Is a Main Determinant of Low Cortical but Not Trabecular Bone MassZhongbo Liu, Tianzhen Han, Haim Werner, et al.
Oncotarget|May 12, 2020
Proteomic analysis of combined IGF1 receptor targeted therapy and chemotherapy identifies signatures associated with survival in breast cancer patientsTali Sinai-Livne, Metsada Pasmanik-Chor, Zoya Cohen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 19, 2009
Tumor suppressor BRCA1 is expressed in prostate cancer and controls insulin-like growth factor I receptor (IGF-IR) gene transcription in an androgen receptor-dependent mannerHagit Schayek, Kathy Haugk, Shihua Sun, et al.
Cells|May 28, 2022
Identification of UDP-Glucuronosyltransferase 2B15 (UGT2B15) as a Target for IGF1 and Insulin ActionRive Sarfstein, Karthik Nagaraj, Shivang Parikh, et al.
Cancer Letters|February 14, 2013
IGF1R-directed targeted therapy enhances the cytotoxic effect of chemotherapy in endometrial cancerConnie Bitelman, Rive Sarfstein, Menahem Sarig, et al.
Cells|June 6, 2020
Effects of GH/IGF on the Aging MitochondriaSher Bahadur Poudel, Manisha Dixit, Maria Neginskaya, et al.
Endocrinology|November 20, 2004
Autocrine activation of the local insulin-like growth factor I system is up-regulated by estrogen receptor (ER)-independent estrogen actions and accounts for decreased ER expression in type 2 diabetic mesangial cellsMichael Karl, Mylene Potier, Ivonne H Schulman, et al.
Pageof 12

Showing results (81-90 of 117) with videos related to

Sort By:
Pageof 12
Endocrinology|May 8, 2004
Transcriptional activation of the insulin-like growth factor I receptor gene by the Kruppel-like factor 6 (KLF6) tumor suppressor protein: potential interactions between KLF6 and p53Moran Rubinstein, Gila Idelman, Stephen R Plymate, et al.
Cancer Letters|May 30, 2006
A novel EWS-WT1 gene fusion product in desmoplastic small round cell tumor is a potent transactivator of the insulin-like growth factor-I receptor (IGF-IR) geneHaim Werner, Gila Idelman, Moran Rubinstein, et al.
European Journal of Cancer (Oxford, England : 1990)|April 1, 2011
Insulin-like growth factor-I receptor (IGF-IR) targeting with monoclonal antibody cixutumumab (IMC-A12) inhibits IGF-I action in endometrial cancer cellsZohar Attias-Geva, Itay Bentov, Dale L Ludwig, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|September 14, 2017
Reduced Serum IGF-1 Associated With Hepatic Osteodystrophy Is a Main Determinant of Low Cortical but Not Trabecular Bone MassZhongbo Liu, Tianzhen Han, Haim Werner, et al.
Oncotarget|May 12, 2020
Proteomic analysis of combined IGF1 receptor targeted therapy and chemotherapy identifies signatures associated with survival in breast cancer patientsTali Sinai-Livne, Metsada Pasmanik-Chor, Zoya Cohen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 19, 2009
Tumor suppressor BRCA1 is expressed in prostate cancer and controls insulin-like growth factor I receptor (IGF-IR) gene transcription in an androgen receptor-dependent mannerHagit Schayek, Kathy Haugk, Shihua Sun, et al.
Cells|May 28, 2022
Identification of UDP-Glucuronosyltransferase 2B15 (UGT2B15) as a Target for IGF1 and Insulin ActionRive Sarfstein, Karthik Nagaraj, Shivang Parikh, et al.
Cancer Letters|February 14, 2013
IGF1R-directed targeted therapy enhances the cytotoxic effect of chemotherapy in endometrial cancerConnie Bitelman, Rive Sarfstein, Menahem Sarig, et al.
Cells|June 6, 2020
Effects of GH/IGF on the Aging MitochondriaSher Bahadur Poudel, Manisha Dixit, Maria Neginskaya, et al.
Endocrinology|November 20, 2004
Autocrine activation of the local insulin-like growth factor I system is up-regulated by estrogen receptor (ER)-independent estrogen actions and accounts for decreased ER expression in type 2 diabetic mesangial cellsMichael Karl, Mylene Potier, Ivonne H Schulman, et al.
Pageof 12